교수진
교수진
최홍조
- 직위 부교수
- 학부 보건정책관리학부
- 연구분야 Public health policy, Implementation science, Health equity, Infectious disease, Global health practice
- 전화번호 02-3290-5665
- 연구실 하나과학관 B동 369호
- 이메일 hongjo@korea.ac.kr
학력
Ph.D. in Health Science, Korea University, Republic of Korea
M.A. in Global Studies, University of Sussex, United Kingdom
M.Med. in Preventive Medicine, Pusan National University, Republic of Korea
B.Med. in Medicine, Dong-A University, Republic of Kore
경력 및 수상
<경력>
2020-2024, Assistant Professor, Department of Preventive Medicine, Konyang University College of Medicine
2015-2020, Head, Research Center, The Korean Institute of Tuberculosis
2010-2014, Research Physician, Department of Clinical Research, International Tuberculosis Research Center
<연구과제>
2026-2028 Project Management Consultant (PMC) Service for the Improving Health and Medical Workforce Management System in Indonesia 인도네시아 보건의료인력 관리체계 개선사업 PMC 용역 (한국국제협력단)
2025-2027 Global treatment effectiveness study on a shorter regimen for multidrug-resistant tuberculosis (I) 다제내성결핵 단기치료법의 다국가 임상 연구 (I) (질병관리청 국립보건연구원)
2025-2026 Study on developing a long-term Tuberculosis (TB) evaluation using TB big data 결핵 빅데이터를 활용한 long-term TB 평가 연구 (질병관리청 국립보건연구원)
2025-2026 A modeling study to estimate the prevalence of latent tuberculosis infection in general population 국내 일반인구의 잠복결핵감염률 모니터링을 위한 추정모델 개발 (질병관리청)
2023-2026 결핵 정밀 의학을 위한 인구집단 역학의 기여: 결핵 제로 전략의 실현을 위한 기반연구 (한국연구재단)
<대외활동>
2026-present, Director of Planning, Academy of Critical Health Policy (건강정책학회)
2026-present, Chair of COVID-19 Vaccine Adverse Event Compensation Appeals Committee (코로나19 예방접종 피해보상 재심위원회)
2026-present, Editorial Board Member, BMC Public Health
2024-present, Editor-in-Chief, Korean Association of Social Policy (한국사회정책학회)
2022-2024, Director of Academic Affairs, Academy of Critical Health Policy (건강정책학회)
2022-2023, Director of General Affairs, The Korean Society for Equity in Health (한국건강형평성학회)
2023-present, Member of Tuberculosis Scientific Committee, Korean Disease Control and Prevention Agency (질병관리청 결핵전문위원회)
2020-2024, Member of Regulatory Review Committee, Korean Disease Control and Prevention Agency (질병관리청 규제심사위원회)
2022-2024, Member of Evaluation Body in Social Welfare Committee, Ministry of Health and Welfare (보건복지부 사회보장위원회)
<수상>
2024, Prime Minister`s Commendation, Republic of Korea – recognized for contribution to infectious disease control
2022, Professor of the Year Award, Konyang University
더보기
2020-2024, Assistant Professor, Department of Preventive Medicine, Konyang University College of Medicine
2015-2020, Head, Research Center, The Korean Institute of Tuberculosis
2010-2014, Research Physician, Department of Clinical Research, International Tuberculosis Research Center
<연구과제>
2026-2028 Project Management Consultant (PMC) Service for the Improving Health and Medical Workforce Management System in Indonesia 인도네시아 보건의료인력 관리체계 개선사업 PMC 용역 (한국국제협력단)
2025-2027 Global treatment effectiveness study on a shorter regimen for multidrug-resistant tuberculosis (I) 다제내성결핵 단기치료법의 다국가 임상 연구 (I) (질병관리청 국립보건연구원)
2025-2026 Study on developing a long-term Tuberculosis (TB) evaluation using TB big data 결핵 빅데이터를 활용한 long-term TB 평가 연구 (질병관리청 국립보건연구원)
2025-2026 A modeling study to estimate the prevalence of latent tuberculosis infection in general population 국내 일반인구의 잠복결핵감염률 모니터링을 위한 추정모델 개발 (질병관리청)
2023-2026 결핵 정밀 의학을 위한 인구집단 역학의 기여: 결핵 제로 전략의 실현을 위한 기반연구 (한국연구재단)
<대외활동>
2026-present, Director of Planning, Academy of Critical Health Policy (건강정책학회)
2026-present, Chair of COVID-19 Vaccine Adverse Event Compensation Appeals Committee (코로나19 예방접종 피해보상 재심위원회)
2026-present, Editorial Board Member, BMC Public Health
2024-present, Editor-in-Chief, Korean Association of Social Policy (한국사회정책학회)
2022-2024, Director of Academic Affairs, Academy of Critical Health Policy (건강정책학회)
2022-2023, Director of General Affairs, The Korean Society for Equity in Health (한국건강형평성학회)
2023-present, Member of Tuberculosis Scientific Committee, Korean Disease Control and Prevention Agency (질병관리청 결핵전문위원회)
2020-2024, Member of Regulatory Review Committee, Korean Disease Control and Prevention Agency (질병관리청 규제심사위원회)
2022-2024, Member of Evaluation Body in Social Welfare Committee, Ministry of Health and Welfare (보건복지부 사회보장위원회)
<수상>
2024, Prime Minister`s Commendation, Republic of Korea – recognized for contribution to infectious disease control
2022, Professor of the Year Award, Konyang University
연구논문
(* Main contribution as the 1st or correspondence author)
Moon, D., Jeong, D., Kang, Y. A., Lee, G. I., & Choi, H*. (2025). Impact of active tuberculosis on social mobility and its gender differences: Difference in differences using nationwide tuberculosis surveillance data and national health insurance data. PloS one, 20(11), e0334961.
Moon, D., & Choi, H. (2025). A sickness benefit for all, leaving no one behind. Ann Occup Environ Med, 37(0), e25-20.
Lee, S. W., Jeon, D., Choi, H., Chung, C., Mok, J., Jeong, D., Sohn, H., & Kang, Y. A. (2025). The impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective study. ERJ Open Res, 11(6), 00191-02025.
Jeong, D., Kim, J., Lee, S. W., Choi, H., Sohn, H., Kim, J., Lee, H., Jeong, H., Lee, S., Park, Y., Kim, J., Kim, E. M., Koo, M., Jang, H., & Kang, Y. A. (2025). Cohort profile: the KDCA-Tuberculosis-NHIS Cohort linking tuberculosis surveillance and health insurance data in Korea. Epidemiol Health, e2025071
Seo, J., Jeong, D., Lee, I-H., Han J., Kwon, Y., Shim, E., & Choi, H*. (2025) Vulnerability assessment and enhanced community-based care and management of patients with tuberculosis in South Korea: a cross-over design. Journal of Preventive Medicine and Public Health. 58:1-9
Choi, H*, Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., & Jeon, D. (2025). Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South Korea. Yonsei Mededical Journal, 66(1):16-24.
Chung, C., Lee, S. W., Jeong, D., Choi, H., Sohn, H., Jeon, D., & Kang, Y. A. (2025). Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020. Journal of Infection and Public Health, 18(5), 102723.
Park, G.-R., Jeong, D., Lee, S.-W., Sohn, H., Kang, Y. A., & Choi, H*. (2024). Homelessness and mortality: gender, age, and housing status inequity in South Korea. Epidemiology and health, 46:e2024076.
Baek, J. Y., Kazmi, S. Z., Lee, H., Hwang, Y., Park, S. J., Shin, M.-H., Lee, J., Choi, H., & Shin, A. (2024). Impact of Mass Screening Using Chest X-Ray on Mortality Reduction and Treatment Adherence Among Pulmonary Tuberculosis Patients. J Korean Med Sci, 39(45), e286.
Bahk, K., Sung, J., Seki, M., Kim, K., Kim, J., Choi, H., Whang, J., & Mitarai, S. (2024). Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis. DNA Research, 31(4)
Moon, D., Jeon, J., Park, J., Choi, M.-H., Kim, M.-H., & Choi, H*. (2024). Universal health coverage saves more lives among severely ill COVID-19 patients: A difference-in-differences analysis of individual patient data in South Korea. Health Research Policy and Systems, 22(1), 116.
Yu, S., Moon, D., Jeong, D., Kang, Y. A., Lee, G. I., & Choi, H*. (2024). Beyond reducing direct medical cost: examining health outcomes in tuberculosis through a difference-in-differences analysis of South Korea’s out-of-pocket payment exception policy. Frontiers in Public Health, 12
Yu, S., Jeong, D., Kang, H.-Y., Kang, Y. A., Lee, G. I., & Choi, H*. (2024). A Quasi-experimental Study on the Effect of Pre-entry Tuberculosis Screening for Immigrants on Treatment Outcomes in South Korea: A Difference-in-Differences Analysis. Journal of Epidemiology and Global Health.
Chung, E., Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H., Kim, H., Choi, H., & Kang, Y. A. (2024). Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study. The Korean journal of internal medicine.
Chung, C., Jeong, D., Sohn, H., Choi, H., & Kang, Y. A. (2024). Low household income increases the risk of tuberculosis recurrence: a retrospective nationwide cohort study in South Korea. Public health, 226, 228-236.
Ki, M. S., Jeong, D., Kang, H. Y., Choi, H., Sohn, H., & Kang, Y. A. (2023). Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data. BMJ Open Respir Res, 10(1).
Jeon, J., Park, J., Choi, M.-H., Choi, H*, & Kim, M.-H. (2023). Unequal burdens of COVID-19 infection: a nationwide cohort study of COVID-19-related health inequalities in South Korea. Epidemiology and health, 45, e2023068.
Choi, H*, Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Jeon, D. (2023). Retreatment after loss to follow-up reduce mortality in patients with multidrug/rifampin-resistant tuberculosis: A retrospective population-based cohort study in South Korea. ERJ Open, 9(4), 00135-2023.
Choi, H*, Jeong, D., Kang, Y-A., Jeon, D., Kang, H-Y., Kim, H-J., Kim H-S., Mok, J. (2023). Impact of anti-tuberculosis drug use on treatment outcomes in patients with pulmonary fluoroquinolone-resistant multidrug-resistant tuberculosis: A nationwide retrospective cohort study with propensity score matching. Tuberculosis & Respiratory Diseases, 86(3), 234-244.
Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Seo, J. M., Choi, H.*, & Kang, Y. A. (2023). Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study. BMJ open, 13(3), e069642.
Moon, D., Jeong, D., Kang, Y. A., & Choi, H*. (2023). Gender differences in tuberculosis patients with comorbidity: A cross-sectional study using national surveillance data and national health insurance claims data in South Korea. PloS one, 18(1), e0280678
Eksombatchai, D., Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Choi, H.*, & Kang, Y. A. (2023). Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. International Journal of Infectious Diseases, 127, 1-10.
Choi, H., Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., & Jeon, D. (2023). Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST). Journal of Korean Medical Science, 38(5).
Jeong D, Kang H-Y, Kim J, Lee H, Yoo B-N, Kim H-S, Choi H*. (2022) Cohort Profile: Korean Tuberculosis and Post-Tuberxculosis Cohort Constructed by Linking the Korean National Tuberculosis Surveillance System and National Health Information Database. Journal of Preventive Medicine and Public Health. 55(3):253-62.
Youn HM, Shin M-K, Jeong D, Kim H-J, Choi H, Kang YA. (2022) Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 17(6):e0268290.
Kim H, Kang YA, Kim H-J, Choi H*. (2022) Heterogeneous effects of COVID-19 control measures on tuberculosis in South Korea: an analysis of case notification data. Respiratory Research, 23(1):56
Kim, J. S., …, Choi, H., Lee, S. H., Kim, H., Yang, J., Kim, H., Shen, X., Alsultan, A., Cho, I., Geiter, L., & Shim, T. S. (2022). Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy, 66(2):e0168421.
Yu, S., Jeong, D., & Choi H*. (2021). The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study. BMC infectious diseases, 21(1):1206
Moon D, Kim S, Kim M-H, Jeong D, Choi H*. (2021) Contracting Out National Immunization Program Does Not Improve Vaccination Rate nor Socioeconomic Inequality: A Case Study of Seasonal Influenza Vaccination in South Korea, Frontiers in Public Health. 9(1690).
Yu S, Sohn H, Kim HY, Kim H, Oh KH, Kim HJ, Chung H, Choi H*. (2021) Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis. PLoS Medicine. 18(7):e1003717.
Choi, H.*, Kim, S-Y., Kim, J-W., Park, Y., Kim, M-H. (2021) Mainstreaming of Health Equity in Infectious Disease Control Policy during the COVID-19 Pandemic Era. Journal of Preventive Medicine and Public Health. 54(1):1-7
Seki, M., Choi, H., Kim, K., Whang, J., Sung J., Mitarai, S. (2021) Tuberculosis: A persistent unpleasant neighbor of humans. Journal of Infection and Public Health. 14(4):508-513
Kim, H., Yu, S., & Choi, H*. (2020). Effects of particulate air pollution on tuberculosis development in seven major cities of Korea from 2010 to 2016: methodological considerations involving long-term exposure and time lag. Epidemiology and Health. 42, e2020012-2020010
Kwak N, Choi H, Jeon D, Jhun BW, Jo K-W, Kang YA, et al. (2020) Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA). Tuberculosis Respiratory Diseases. 83(2):141-146
Kim H, Choi H*, Yu S, Lee A-Y, Kim H-O, Joh J, Heo EY, Oh K-H, Kim HJ, Chung H (2019) Impact of Housing Provision Package on Treatment Outcome among Homeless Tuberculosis Patients in South Korea. Asia Pacific Journal of Public Health. 31(7):603-11
Choi H*, Chung H, Muntaner C (2019) Social selection in historical time: The case of tuberculosis in South Korea after the East Asian financial crisis. PLOS ONE 14(5): e0217055
Kim H, Kim HJ, Oh KH, Oh HW, Choi H* (2019). A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Province. Tuberculosis Respiratory Diseases. 82(3), 194-200.
Sohn M, Kim H, Sung H, Lee Y, Choi H, Chung H (2019). Association of social deprivation and outdoor air pollution with pulmonary tuberculosis in spatiotemporal analysis. International Journal of Environmental Health Research, 29(6):657-67.
Min, J., Kim, K., Choi, H., Kang, E. S., Shin, Y. M., An, J. Y., Choe, K. H., Lee, K. M. (2019). Investigation of false-positive Mycobacterium tuberculosis culture tests using whole genome sequencing. Annals of Thoracic Medicine, 14(1), 90.
Oh, K. H., Rahevar, K., Nishikiori, N., Viney, K., Choi, H., et al. (2018). Action towards Universal Health Coverage and Social Protection for Tuberculosis Care and Prevention: Workshop on the End TB Strategy Pillar 2 in the Western Pacific Region 2017. Tropical Medicine and Infectious Disease, 4(1).
Kang, M., Yang, J. S., Kim, Y., Kim, K., Choi, H., & Lee, S. H. (2018). Comparison of DNA extraction methods for drug susceptibility testing by allele-specific primer extension on a microsphere-based platform: Chelex-100 (in-house and commercialized) and MagPurix TB DNA Extraction Kit. Journal of Microbiological Methods, 152, 105-108.
Yang, J. S., Kim, K. J., Choi, H., & Lee, S. H. (2018). Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea. Annals of Laboratory Medicine, 38(6), 563-568.
Kim, K., Yang, J. S., Choi, H., Kim, H., Park, S.-H., Jeon, S.-M., Lim, N.-R., Kim, C. (2018). A molecular epidemiological analysis of tuberculosis trends in South Korea. Tuberculosis, 111:127-134
Kim, Y., Kim, B. K., Choi, H. J., Ryu, S. W., Kim, E. S., Chang, Y. S., et al. (2017). Lessons learned from continued TB outbreaks in a high school. PLoS ONE, 12(11), e0188076.
Oh, K-H., Choi, H., Kim, E., Kim, H-J., Cho, S-I. (2017) Depression and Risk of Tuberculosis: A Nationwide Population-based Cohort Study. International Journal of Tuberculosis and Lung Disease. 21(7): 804-809
Malherbe, S. T., …, Choi, H., et al. (2016) Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nature Medicine. 22:1094-1100
Choi, H.*, Chung, H., et al. (2016) The Impacts of Social Conditions on Patients` Adherence to Pulmonary Tuberculosis Treatment. International Journal of Tuberculosis and Lung Disease, 20(7):948-954.
Lee, H-J., Choi, H-J, et al. (2016) Safety and Efficacy of Tuberculin Skin Testing with Microneedle MicronJet600TM in Healthy Adults. International Journal of Tuberculosis and Lung Disease, 20(4):500-504.
Choi, H.*, Lee, M., et al. (2014) Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infectious Diseases, 14(1):360.
Choi, H.*, Kim, M-H., Chung, H. (2014) Present and Future of Tuberculosis Research from the Perspective of Social Determinants of Tuberculosis in South Korea. Health and Social Science, 35:145-174. (Korean)
Song, T., Park, Y., Shamputa, I. C., Seo, S., Lee, S-Y., Jeon, H‐S., Choi, H., et al. (2014) Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β′ subunit of RNA polymerase. Molecular microbiology, 91(6):1106-1119
Reed, G. W., Choi, H., et al. (2013) Impact of Diabetes and Smoking on Mortality in Tuberculosis. PLoS ONE, 8(2):e58044.
Lee M., Lee, J., Carroll, M. W., Choi, H., et al. (2012) Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 367(16):1508-1518.
Joh, J-S, Hong, H C., Jeong, I-A, Chin, B-S, Yang, H-J, Choi, H., Bang, J-H. (2012) Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea. Journal of Korean medical science, 27(10):1143-1146.
Carroll, M., Choi, H., et al. (2012) Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis. Clinical Infectious Diseases, 54(11):1624-1627.
Choi, H. J.*, Cho, B. M., Hwang, I. K., Yoon, T. H. (2009) Factors related to psychosocial stress level of residents living near the Gori Nuclear Power Plant. Health and Social Science, 25:153-176. (Korean)
더보기
Moon, D., Jeong, D., Kang, Y. A., Lee, G. I., & Choi, H*. (2025). Impact of active tuberculosis on social mobility and its gender differences: Difference in differences using nationwide tuberculosis surveillance data and national health insurance data. PloS one, 20(11), e0334961.
Moon, D., & Choi, H. (2025). A sickness benefit for all, leaving no one behind. Ann Occup Environ Med, 37(0), e25-20.
Lee, S. W., Jeon, D., Choi, H., Chung, C., Mok, J., Jeong, D., Sohn, H., & Kang, Y. A. (2025). The impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective study. ERJ Open Res, 11(6), 00191-02025.
Jeong, D., Kim, J., Lee, S. W., Choi, H., Sohn, H., Kim, J., Lee, H., Jeong, H., Lee, S., Park, Y., Kim, J., Kim, E. M., Koo, M., Jang, H., & Kang, Y. A. (2025). Cohort profile: the KDCA-Tuberculosis-NHIS Cohort linking tuberculosis surveillance and health insurance data in Korea. Epidemiol Health, e2025071
Seo, J., Jeong, D., Lee, I-H., Han J., Kwon, Y., Shim, E., & Choi, H*. (2025) Vulnerability assessment and enhanced community-based care and management of patients with tuberculosis in South Korea: a cross-over design. Journal of Preventive Medicine and Public Health. 58:1-9
Choi, H*, Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., & Jeon, D. (2025). Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South Korea. Yonsei Mededical Journal, 66(1):16-24.
Chung, C., Lee, S. W., Jeong, D., Choi, H., Sohn, H., Jeon, D., & Kang, Y. A. (2025). Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020. Journal of Infection and Public Health, 18(5), 102723.
Park, G.-R., Jeong, D., Lee, S.-W., Sohn, H., Kang, Y. A., & Choi, H*. (2024). Homelessness and mortality: gender, age, and housing status inequity in South Korea. Epidemiology and health, 46:e2024076.
Baek, J. Y., Kazmi, S. Z., Lee, H., Hwang, Y., Park, S. J., Shin, M.-H., Lee, J., Choi, H., & Shin, A. (2024). Impact of Mass Screening Using Chest X-Ray on Mortality Reduction and Treatment Adherence Among Pulmonary Tuberculosis Patients. J Korean Med Sci, 39(45), e286.
Bahk, K., Sung, J., Seki, M., Kim, K., Kim, J., Choi, H., Whang, J., & Mitarai, S. (2024). Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosis. DNA Research, 31(4)
Moon, D., Jeon, J., Park, J., Choi, M.-H., Kim, M.-H., & Choi, H*. (2024). Universal health coverage saves more lives among severely ill COVID-19 patients: A difference-in-differences analysis of individual patient data in South Korea. Health Research Policy and Systems, 22(1), 116.
Yu, S., Moon, D., Jeong, D., Kang, Y. A., Lee, G. I., & Choi, H*. (2024). Beyond reducing direct medical cost: examining health outcomes in tuberculosis through a difference-in-differences analysis of South Korea’s out-of-pocket payment exception policy. Frontiers in Public Health, 12
Yu, S., Jeong, D., Kang, H.-Y., Kang, Y. A., Lee, G. I., & Choi, H*. (2024). A Quasi-experimental Study on the Effect of Pre-entry Tuberculosis Screening for Immigrants on Treatment Outcomes in South Korea: A Difference-in-Differences Analysis. Journal of Epidemiology and Global Health.
Chung, E., Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H., Kim, H., Choi, H., & Kang, Y. A. (2024). Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study. The Korean journal of internal medicine.
Chung, C., Jeong, D., Sohn, H., Choi, H., & Kang, Y. A. (2024). Low household income increases the risk of tuberculosis recurrence: a retrospective nationwide cohort study in South Korea. Public health, 226, 228-236.
Ki, M. S., Jeong, D., Kang, H. Y., Choi, H., Sohn, H., & Kang, Y. A. (2023). Real-world impact of the fixed-dose combination on improving treatment outcomes of drug-susceptible tuberculosis: a comparative study using multiyear national tuberculosis patient data. BMJ Open Respir Res, 10(1).
Jeon, J., Park, J., Choi, M.-H., Choi, H*, & Kim, M.-H. (2023). Unequal burdens of COVID-19 infection: a nationwide cohort study of COVID-19-related health inequalities in South Korea. Epidemiology and health, 45, e2023068.
Choi, H*, Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Jeon, D. (2023). Retreatment after loss to follow-up reduce mortality in patients with multidrug/rifampin-resistant tuberculosis: A retrospective population-based cohort study in South Korea. ERJ Open, 9(4), 00135-2023.
Choi, H*, Jeong, D., Kang, Y-A., Jeon, D., Kang, H-Y., Kim, H-J., Kim H-S., Mok, J. (2023). Impact of anti-tuberculosis drug use on treatment outcomes in patients with pulmonary fluoroquinolone-resistant multidrug-resistant tuberculosis: A nationwide retrospective cohort study with propensity score matching. Tuberculosis & Respiratory Diseases, 86(3), 234-244.
Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Seo, J. M., Choi, H.*, & Kang, Y. A. (2023). Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study. BMJ open, 13(3), e069642.
Moon, D., Jeong, D., Kang, Y. A., & Choi, H*. (2023). Gender differences in tuberculosis patients with comorbidity: A cross-sectional study using national surveillance data and national health insurance claims data in South Korea. PloS one, 18(1), e0280678
Eksombatchai, D., Jeong, D., Mok, J., Jeon, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., Choi, H.*, & Kang, Y. A. (2023). Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. International Journal of Infectious Diseases, 127, 1-10.
Choi, H., Mok, J., Kang, Y. A., Jeong, D., Kang, H.-Y., Kim, H. J., Kim, H.-S., & Jeon, D. (2023). Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST). Journal of Korean Medical Science, 38(5).
Jeong D, Kang H-Y, Kim J, Lee H, Yoo B-N, Kim H-S, Choi H*. (2022) Cohort Profile: Korean Tuberculosis and Post-Tuberxculosis Cohort Constructed by Linking the Korean National Tuberculosis Surveillance System and National Health Information Database. Journal of Preventive Medicine and Public Health. 55(3):253-62.
Youn HM, Shin M-K, Jeong D, Kim H-J, Choi H, Kang YA. (2022) Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 17(6):e0268290.
Kim H, Kang YA, Kim H-J, Choi H*. (2022) Heterogeneous effects of COVID-19 control measures on tuberculosis in South Korea: an analysis of case notification data. Respiratory Research, 23(1):56
Kim, J. S., …, Choi, H., Lee, S. H., Kim, H., Yang, J., Kim, H., Shen, X., Alsultan, A., Cho, I., Geiter, L., & Shim, T. S. (2022). Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy, 66(2):e0168421.
Yu, S., Jeong, D., & Choi H*. (2021). The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study. BMC infectious diseases, 21(1):1206
Moon D, Kim S, Kim M-H, Jeong D, Choi H*. (2021) Contracting Out National Immunization Program Does Not Improve Vaccination Rate nor Socioeconomic Inequality: A Case Study of Seasonal Influenza Vaccination in South Korea, Frontiers in Public Health. 9(1690).
Yu S, Sohn H, Kim HY, Kim H, Oh KH, Kim HJ, Chung H, Choi H*. (2021) Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis. PLoS Medicine. 18(7):e1003717.
Choi, H.*, Kim, S-Y., Kim, J-W., Park, Y., Kim, M-H. (2021) Mainstreaming of Health Equity in Infectious Disease Control Policy during the COVID-19 Pandemic Era. Journal of Preventive Medicine and Public Health. 54(1):1-7
Seki, M., Choi, H., Kim, K., Whang, J., Sung J., Mitarai, S. (2021) Tuberculosis: A persistent unpleasant neighbor of humans. Journal of Infection and Public Health. 14(4):508-513
Kim, H., Yu, S., & Choi, H*. (2020). Effects of particulate air pollution on tuberculosis development in seven major cities of Korea from 2010 to 2016: methodological considerations involving long-term exposure and time lag. Epidemiology and Health. 42, e2020012-2020010
Kwak N, Choi H, Jeon D, Jhun BW, Jo K-W, Kang YA, et al. (2020) Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA). Tuberculosis Respiratory Diseases. 83(2):141-146
Kim H, Choi H*, Yu S, Lee A-Y, Kim H-O, Joh J, Heo EY, Oh K-H, Kim HJ, Chung H (2019) Impact of Housing Provision Package on Treatment Outcome among Homeless Tuberculosis Patients in South Korea. Asia Pacific Journal of Public Health. 31(7):603-11
Choi H*, Chung H, Muntaner C (2019) Social selection in historical time: The case of tuberculosis in South Korea after the East Asian financial crisis. PLOS ONE 14(5): e0217055
Kim H, Kim HJ, Oh KH, Oh HW, Choi H* (2019). A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Province. Tuberculosis Respiratory Diseases. 82(3), 194-200.
Sohn M, Kim H, Sung H, Lee Y, Choi H, Chung H (2019). Association of social deprivation and outdoor air pollution with pulmonary tuberculosis in spatiotemporal analysis. International Journal of Environmental Health Research, 29(6):657-67.
Min, J., Kim, K., Choi, H., Kang, E. S., Shin, Y. M., An, J. Y., Choe, K. H., Lee, K. M. (2019). Investigation of false-positive Mycobacterium tuberculosis culture tests using whole genome sequencing. Annals of Thoracic Medicine, 14(1), 90.
Oh, K. H., Rahevar, K., Nishikiori, N., Viney, K., Choi, H., et al. (2018). Action towards Universal Health Coverage and Social Protection for Tuberculosis Care and Prevention: Workshop on the End TB Strategy Pillar 2 in the Western Pacific Region 2017. Tropical Medicine and Infectious Disease, 4(1).
Kang, M., Yang, J. S., Kim, Y., Kim, K., Choi, H., & Lee, S. H. (2018). Comparison of DNA extraction methods for drug susceptibility testing by allele-specific primer extension on a microsphere-based platform: Chelex-100 (in-house and commercialized) and MagPurix TB DNA Extraction Kit. Journal of Microbiological Methods, 152, 105-108.
Yang, J. S., Kim, K. J., Choi, H., & Lee, S. H. (2018). Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea. Annals of Laboratory Medicine, 38(6), 563-568.
Kim, K., Yang, J. S., Choi, H., Kim, H., Park, S.-H., Jeon, S.-M., Lim, N.-R., Kim, C. (2018). A molecular epidemiological analysis of tuberculosis trends in South Korea. Tuberculosis, 111:127-134
Kim, Y., Kim, B. K., Choi, H. J., Ryu, S. W., Kim, E. S., Chang, Y. S., et al. (2017). Lessons learned from continued TB outbreaks in a high school. PLoS ONE, 12(11), e0188076.
Oh, K-H., Choi, H., Kim, E., Kim, H-J., Cho, S-I. (2017) Depression and Risk of Tuberculosis: A Nationwide Population-based Cohort Study. International Journal of Tuberculosis and Lung Disease. 21(7): 804-809
Malherbe, S. T., …, Choi, H., et al. (2016) Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nature Medicine. 22:1094-1100
Choi, H.*, Chung, H., et al. (2016) The Impacts of Social Conditions on Patients` Adherence to Pulmonary Tuberculosis Treatment. International Journal of Tuberculosis and Lung Disease, 20(7):948-954.
Lee, H-J., Choi, H-J, et al. (2016) Safety and Efficacy of Tuberculin Skin Testing with Microneedle MicronJet600TM in Healthy Adults. International Journal of Tuberculosis and Lung Disease, 20(4):500-504.
Choi, H.*, Lee, M., et al. (2014) Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infectious Diseases, 14(1):360.
Choi, H.*, Kim, M-H., Chung, H. (2014) Present and Future of Tuberculosis Research from the Perspective of Social Determinants of Tuberculosis in South Korea. Health and Social Science, 35:145-174. (Korean)
Song, T., Park, Y., Shamputa, I. C., Seo, S., Lee, S-Y., Jeon, H‐S., Choi, H., et al. (2014) Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β′ subunit of RNA polymerase. Molecular microbiology, 91(6):1106-1119
Reed, G. W., Choi, H., et al. (2013) Impact of Diabetes and Smoking on Mortality in Tuberculosis. PLoS ONE, 8(2):e58044.
Lee M., Lee, J., Carroll, M. W., Choi, H., et al. (2012) Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 367(16):1508-1518.
Joh, J-S, Hong, H C., Jeong, I-A, Chin, B-S, Yang, H-J, Choi, H., Bang, J-H. (2012) Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea. Journal of Korean medical science, 27(10):1143-1146.
Carroll, M., Choi, H., et al. (2012) Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis. Clinical Infectious Diseases, 54(11):1624-1627.
Choi, H. J.*, Cho, B. M., Hwang, I. K., Yoon, T. H. (2009) Factors related to psychosocial stress level of residents living near the Gori Nuclear Power Plant. Health and Social Science, 25:153-176. (Korean)
학부,대학원 담당과목
KHPM328 INFECTIOUS DISEASE CONTROL POLICY (감염병 관리 정책학)
KHPM429 HPM CAPSTONE Ⅲ: HEALTH PLANNING AND IMPLEMENTATION (캡스톤Ⅲ: 보건사업의 기획과 실행)
HCS531 POLITICS OF GLOBAL HEALTH (국제보건의 정치학)
HEL945 POLITICS OF PUBLIC HEALTH POLIC (보건정책의 정치학)
HEL947 METHODS FOR HEALTH EQUITY STUDIES (건강형평성 연구방법론)
HCS505 IMPLEMENTATION SCIENCE IN PUBLIC HEALTH (보건학 실행연구)
더보기
KHPM429 HPM CAPSTONE Ⅲ: HEALTH PLANNING AND IMPLEMENTATION (캡스톤Ⅲ: 보건사업의 기획과 실행)
HCS531 POLITICS OF GLOBAL HEALTH (국제보건의 정치학)
HEL945 POLITICS OF PUBLIC HEALTH POLIC (보건정책의 정치학)
HEL947 METHODS FOR HEALTH EQUITY STUDIES (건강형평성 연구방법론)
HCS505 IMPLEMENTATION SCIENCE IN PUBLIC HEALTH (보건학 실행연구)
